Pacira BioSciences Inc
Pacira BioSciences Inc (PCRX) Implied Volatility Current
PCRX implied volatility is 61%. IV Rank is 42%, placing current premiums in the middle of their 52-week range.
Read more
Tracking PCRX implied volatility helps you identify when options premiums on Pacira BioSciences Inc are historically cheap or expensive, and where the best trades are hiding. Pacira BioSciences Inc implied volatility reflects the market's expectation of future price movement: when PCRX IV rises, option premiums increase, creating opportunities for sellers, and when it drops, buyers can find cheaper contracts. Use our scanner to monitor Pacira BioSciences Inc's implied volatility current levels in real time and filter for high-probability trades.
Implied volatility is derived from option prices using models like Black-Scholes and represents the annualized expected move of an underlying stock. For PCRX, tracking metrics like PCRX IV rank helps traders understand whether current implied volatility is historically high or low. IV rank compares today's reading against the past year's range — a high rank on PCRX signals rich premiums and potential mean-reversion, while a low rank may favor long options strategies.
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid handheld cryoanalgesia device used to produce controlled doses of cold temperature only to targeted nerves. It also develops proprietary multivesicular liposome, a drug delivery technology that encapsulates drugs without altering their molecular structure.
The company was formerly known as Pacira Pharmaceuticals, Inc. and changed its name to Pacira BioSciences, Inc. in April 2019. Pacira BioSciences, Inc. was incorporated in 2006 and is headquartered in Tampa, Florida.
Premium sellers, directional traders, and spread builders all need the same starting point: a clear read on where PCRX implied volatility sits today versus where it has been. Our scanner ranks Pacira BioSciences Inc implied volatility against its historical range, surfaces extremes in PCRX IV rank, and pairs every reading with the trades that exploit it. Stop guessing whether Pacira BioSciences Inc IV is rich or cheap — measure it, then act on it.
Implied Volatility
IV is below its typical range - premiums look reasonable for buyers.
As of September 24, 2026
Trade options with IV on your side
Track PCRX IV rank across every expiration, spot where volatility is elevated, and identify high-probability setups before the window closes.
Start your 14-day free trial→